Palliative Care for Patients on Extracorporeal Membrane Oxygenation for COVID-19 Infection.

COVID-19 acute respiratory distress syndrome extracorporeal membrane oxygenation palliative care

Journal

The American journal of hospice & palliative care
ISSN: 1938-2715
Titre abrégé: Am J Hosp Palliat Care
Pays: United States
ID NLM: 9008229

Informations de publication

Date de publication:
Jul 2021
Historique:
pubmed: 10 3 2021
medline: 2 7 2021
entrez: 9 3 2021
Statut: ppublish

Résumé

Critically ill patients with COVID-19 infection on extracorporeal membrane oxygenation (ECMO) face high morbidity and mortality. Palliative care consultation may benefit these patients and their families. Prior to the pandemic, our institution implemented a policy of automatic palliative care consultation for all patients on ECMO due to the high mortality, medical complexity, and psychosocial distress associated with these cases. The main objective was to describe the role of the palliative care team for patients on ECMO for COVID-19 infection. The secondary objective was to describe the clinical outcomes for this cohort. Case series. All patients age 18 or older infected by the novel coronavirus who required cannulation on ECMO from March through July of 2020, at an urban, academic medical center in the United States. Inter-disciplinary palliative care consultation occurred for all patients. Twenty-three patients (median age 43 years [range 28-64], mean body mass index 34.9 kg/m2 [SD 9.2], 65% Hispanic ethnicity) were cannulated on ECMO. Eleven patients died during the hospitalization (48%). Patients older than 50 years of age demonstrated a trend toward increased odds of death compared to those younger than 50 years of age (OR 9.1, Here, we present one of the first studies describing the patient characteristics, outcomes, and palliative care actions for critically ill patients with COVID-19 on ECMO. Almost half of the patients in this cohort died during their hospitalization. Given the high morbidity and mortality of this condition, we recommend involvement of palliative care for patients/families with COVID-19 infection who are on ECMO. The impact of palliative care on patient and family outcomes, such as symptom control, satisfaction with communication, rates of anxiety, and grief experience merits further investigation.

Sections du résumé

BACKGROUND BACKGROUND
Critically ill patients with COVID-19 infection on extracorporeal membrane oxygenation (ECMO) face high morbidity and mortality. Palliative care consultation may benefit these patients and their families. Prior to the pandemic, our institution implemented a policy of automatic palliative care consultation for all patients on ECMO due to the high mortality, medical complexity, and psychosocial distress associated with these cases.
OBJECTIVES OBJECTIVE
The main objective was to describe the role of the palliative care team for patients on ECMO for COVID-19 infection. The secondary objective was to describe the clinical outcomes for this cohort.
DESIGN METHODS
Case series.
SETTINGS/SUBJECTS METHODS
All patients age 18 or older infected by the novel coronavirus who required cannulation on ECMO from March through July of 2020, at an urban, academic medical center in the United States. Inter-disciplinary palliative care consultation occurred for all patients.
RESULTS RESULTS
Twenty-three patients (median age 43 years [range 28-64], mean body mass index 34.9 kg/m2 [SD 9.2], 65% Hispanic ethnicity) were cannulated on ECMO. Eleven patients died during the hospitalization (48%). Patients older than 50 years of age demonstrated a trend toward increased odds of death compared to those younger than 50 years of age (OR 9.1,
CONCLUSIONS CONCLUSIONS
Here, we present one of the first studies describing the patient characteristics, outcomes, and palliative care actions for critically ill patients with COVID-19 on ECMO. Almost half of the patients in this cohort died during their hospitalization. Given the high morbidity and mortality of this condition, we recommend involvement of palliative care for patients/families with COVID-19 infection who are on ECMO. The impact of palliative care on patient and family outcomes, such as symptom control, satisfaction with communication, rates of anxiety, and grief experience merits further investigation.

Identifiants

pubmed: 33685240
doi: 10.1177/10499091211001009
pmc: PMC7944020
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

854-860

Auteurs

Anirudh Rao (A)

Department of Medicine, 12230Georgetown University School of Medicine, Washington, DC, USA.
Department of Medicine, Section of Palliative Care, 8405MedStar Washington Hospital Center, Washington, DC, USA.

Akram M Zaaqoq (AM)

Department of Medicine, 12230Georgetown University School of Medicine, Washington, DC, USA.
Department of Critical Care Medicine, 8405MedStar Washington Hospital Center, Washington, DC, USA.

In Guk Kang (IG)

Department of Medicine, 12230Georgetown University School of Medicine, Washington, DC, USA.

Erin M Vaughan (EM)

Department of Medicine, 12230Georgetown University School of Medicine, Washington, DC, USA.

Jose Flores (J)

12228Yale University School of Medicine, New Haven, CT, USA.

Victor J Avila-Quintero (VJ)

12228Yale University School of Medicine, New Haven, CT, USA.

Muhtadi H Alnababteh (MH)

Department of Critical Care Medicine, 8405MedStar Washington Hospital Center, Washington, DC, USA.

Anne M Kelemen (AM)

Department of Medicine, 12230Georgetown University School of Medicine, Washington, DC, USA.
Department of Medicine, Section of Palliative Care, 8405MedStar Washington Hospital Center, Washington, DC, USA.

Hunter Groninger (H)

Department of Medicine, 12230Georgetown University School of Medicine, Washington, DC, USA.
Department of Medicine, Section of Palliative Care, 8405MedStar Washington Hospital Center, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH